Joana Calvão
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joana Calvão has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
- Margarida Gonçalo
Department of Dermatology University Hospital, Unidade Local de Saude de Coimbra Coimbra Portugal
12 shared publications - José Carlos Cardoso
Dermatology and Venereology Department Unidade Local de Saúde de Coimbra Coimbra Portugal
10 shared publications Leonor Ramos
Coimbra Local Health Unit, Dermatology Department University Hospital Coimbra Portugal
6 shared publications- Maria Relvas
Dermatology Department, Centro Hospitalar e Universitário de Coimbra, Praceta Prof. Mota Pinto, Coimbra, Portugal
5 shared publications - Ricardo Vieira
Department of Dermatology, Coimbra University Hospital, Coimbra, Portugal
5 shared publications - Ana Brinca
Department of Dermatology, Coimbra University Hospital, Coimbra, Portugal
4 shared publications
Latest Publications
- 8 September 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
Primary cutaneous lymphomas: diagnostic burden and determinants of diagnostic delay across the disease spectrum
In a 15-year cohort of 265 patients with primary cutaneous lymphomas, diagnostic delay was shaped by lesion morphology and the initial diagnostic impression. Nodular/tumoral lesions were diagnosed earlier, whereas presentations initially interpreted as benign inflammatory dermatoses, particularly psoriasis, showed longer delay. Diagnostic delay did not predict adverse outcome.
- 8 September 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
Primary cutaneous lymphomas: diagnostic burden and determinants of diagnostic delay across the disease spectrum
In a 15-year cohort of 265 patients with primary cutaneous lymphomas, diagnostic delay was shaped by lesion morphology and the initial diagnostic impression. Nodular/tumoral lesions were diagnosed earlier, whereas presentations initially interpreted as benign inflammatory dermatoses, particularly psoriasis, showed longer delay. Diagnostic delay did not predict adverse outcome.
- 5 July 2026
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
Cutaneous embryology: Physiological basis and clinical implications
Skin development is a tightly regulated, multistep process that transforms the embryonic surface into a complex organ composed of a stratified epidermis, dermal–epidermal junction, dermis, hypodermis and cutaneous appendages. This review provides a compartment‐based, clinically oriented overview of human skin embryology, linking key developmental pathways to normal structure and inherited skin disorders. The epidermis arises from surface ectoderm through the coordinated activity of bone morphogenetic protein (BMP) and Wnt signalling, with p63 maintaining the basal progenitor compartment required for stratification. Subsequent keratinocyte differentiation, cornification and barrier maturation also depend on Notch, lipid‐processing and desquamation pathways. Disruption of these sequential events helps explain epidermal mosaic disorders and congenital ichthyoses. In parallel, melanocytes derive from neural crest precursors and colonize the developing epidermis and hair follicles through microphthalmia‐associated transcription factor (MITF)‐centred melanocytic programmes; abnormal migration, survival or pigment production underlies several congenital pigmentary disorders. The dermal–epidermal junction forms as hemidesmosomes and collagen VII‐containing anchoring fibrils progressively secure adhesion between epidermis and dermis; defects in these structures underlie inherited forms of epidermolysis bullosa. The dermis develops from BMP‐patterned mesenchyme into papillary and reticular compartments, where fibroblast differentiation, extracellular matrix production, vascularization and foetal repair programmes shape connective tissue strength, vascular patterning and wound‐healing behaviour. Disruption of these processes contributes to connective tissue disorders, vascular anomalies and congenital defects of repair. The hypodermis forms through progressive adipogenic differentiation, from early mesenchymal commitment to later peroxisome proliferator‐activated receptor gamma (PPARγ)‐mediated adipocyte maturation, with disruption reflected clinically by lipodystrophy syndromes. Finally, skin appendages arise through reciprocal epithelial–mesenchymal interactions, initiated by Wnt/β‐catenin signalling and refined by ectodysplasin/NF‐κB, Sonic Hedgehog, Notch and connexin‐mediated pathways. Defects in these shared developmental programmes provide the basis for ectodermal dysplasias. Understanding this developmental trajectory provides a unifying framework for interpreting skin disease, clarifying how timing, context and cellular origin shape clinical outcomes.
- 5 July 2026
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
Cutaneous embryology: Physiological basis and clinical implications
Skin development is a tightly regulated, multistep process that transforms the embryonic surface into a complex organ composed of a stratified epidermis, dermal–epidermal junction, dermis, hypodermis and cutaneous appendages. This review provides a compartment‐based, clinically oriented overview of human skin embryology, linking key developmental pathways to normal structure and inherited skin disorders. The epidermis arises from surface ectoderm through the coordinated activity of bone morphogenetic protein (BMP) and Wnt signalling, with p63 maintaining the basal progenitor compartment required for stratification. Subsequent keratinocyte differentiation, cornification and barrier maturation also depend on Notch, lipid‐processing and desquamation pathways. Disruption of these sequential events helps explain epidermal mosaic disorders and congenital ichthyoses. In parallel, melanocytes derive from neural crest precursors and colonize the developing epidermis and hair follicles through microphthalmia‐associated transcription factor (MITF)‐centred melanocytic programmes; abnormal migration, survival or pigment production underlies several congenital pigmentary disorders. The dermal–epidermal junction forms as hemidesmosomes and collagen VII‐containing anchoring fibrils progressively secure adhesion between epidermis and dermis; defects in these structures underlie inherited forms of epidermolysis bullosa. The dermis develops from BMP‐patterned mesenchyme into papillary and reticular compartments, where fibroblast differentiation, extracellular matrix production, vascularization and foetal repair programmes shape connective tissue strength, vascular patterning and wound‐healing behaviour. Disruption of these processes contributes to connective tissue disorders, vascular anomalies and congenital defects of repair. The hypodermis forms through progressive adipogenic differentiation, from early mesenchymal commitment to later peroxisome proliferator‐activated receptor gamma (PPARγ)‐mediated adipocyte maturation, with disruption reflected clinically by lipodystrophy syndromes. Finally, skin appendages arise through reciprocal epithelial–mesenchymal interactions, initiated by Wnt/β‐catenin signalling and refined by ectodysplasin/NF‐κB, Sonic Hedgehog, Notch and connexin‐mediated pathways. Defects in these shared developmental programmes provide the basis for ectodermal dysplasias. Understanding this developmental trajectory provides a unifying framework for interpreting skin disease, clarifying how timing, context and cellular origin shape clinical outcomes.
- Open Access
- 11 April 2026
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 157 (6) , 1237-1245
Dupilumab therapy in atopic dermatitis when cutaneous lymphoma is suspected: Consensus recommendations from the EORTC Cutaneous Lymphoma Tumour Group
- 11 April 2026
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 157 (6) , 1237-1245
Open AccessDupilumab therapy in atopic dermatitis when cutaneous lymphoma is suspected: Consensus recommendations from the EORTC Cutaneous Lymphoma Tumour Group
- Open Access
- 19 February 2026
- Published by Wiley in British Journal of Haematology
- Vol. 208 (4) , 1207-1210
Mycosis fungoides and Sézary syndrome
Summary: Mycosis fungoides (MF) and Sézary syndrome (SS) are the most common cutaneous T‐cell lymphomas, arising from mature CD4 + memory T cells. Diagnosis is complex and relies on clinicopathological correlation, immunophenotyping and molecular clonality testing, while management is stage‐adapted, with potentially curative outcomes achievable only in selected patients through allogeneic haematopoietic stem cell transplantation.
- 19 February 2026
- Published by Wiley in British Journal of Haematology
- Vol. 208 (4) , 1207-1210
Open AccessMycosis fungoides and Sézary syndrome
Summary: Mycosis fungoides (MF) and Sézary syndrome (SS) are the most common cutaneous T‐cell lymphomas, arising from mature CD4 + memory T cells. Diagnosis is complex and relies on clinicopathological correlation, immunophenotyping and molecular clonality testing, while management is stage‐adapted, with potentially curative outcomes achievable only in selected patients through allogeneic haematopoietic stem cell transplantation.
- Open Access
Methicillin-Susceptible Staphylococcus aureus ST398 in atopic dermatitis in Portugal displays pathogenic traits associated with impaired skin barrier function
Staphylococcus aureus plays a central role in the exacerbation of atopic dermatitis (AD), but the population structure and pathogenic determinants of strains colonizing AD patients remain poorly understood. It is unclear whether these strains mirror those circulating in the general community or whether specific clonal lineages are selectively adapted to the AD skin microenvironment. Data addressing this question are scarce, particularly in Portugal. In this study, we investigated the molecular epidemiology and pathogenic traits of S. aureus colonizing skin lesions in adult patients with AD in Portugal. We found that lesion-associated isolates belonged predominantly to the methicillin-susceptible S. aureus MSSA-ST398 clonal type, a lineage that is widely circulating in the Portuguese community, particularly among vulnerable populations, and that has also been implicated in severe human infections. Notably, isolates from this clonal type in AD harboured specific pathogenicity traits associated with skin barrier disruption, including hemolysin and urease production, which may contribute to their success as colonizers in AD. Our findings highlight that S. aureus colonization in AD arises from a dynamic interplay between community-level molecular epidemiology and disease-specific selective pressures. While circulating lineages provide the genetic background diversity, the AD skin microenvironment appears to shape which clones ultimately become dominant. Such an integrated perspective may help to inform future geographically tailored strategies aimed at limiting bacterial burden and preventing disease exacerbation in AD.
Open AccessMethicillin-Susceptible Staphylococcus aureus ST398 in atopic dermatitis in Portugal displays pathogenic traits associated with impaired skin barrier function
Staphylococcus aureus plays a central role in the exacerbation of atopic dermatitis (AD), but the population structure and pathogenic determinants of strains colonizing AD patients remain poorly understood. It is unclear whether these strains mirror those circulating in the general community or whether specific clonal lineages are selectively adapted to the AD skin microenvironment. Data addressing this question are scarce, particularly in Portugal. In this study, we investigated the molecular epidemiology and pathogenic traits of S. aureus colonizing skin lesions in adult patients with AD in Portugal. We found that lesion-associated isolates belonged predominantly to the methicillin-susceptible S. aureus MSSA-ST398 clonal type, a lineage that is widely circulating in the Portuguese community, particularly among vulnerable populations, and that has also been implicated in severe human infections. Notably, isolates from this clonal type in AD harboured specific pathogenicity traits associated with skin barrier disruption, including hemolysin and urease production, which may contribute to their success as colonizers in AD. Our findings highlight that S. aureus colonization in AD arises from a dynamic interplay between community-level molecular epidemiology and disease-specific selective pressures. While circulating lineages provide the genetic background diversity, the AD skin microenvironment appears to shape which clones ultimately become dominant. Such an integrated perspective may help to inform future geographically tailored strategies aimed at limiting bacterial burden and preventing disease exacerbation in AD.
- Open Access
- 22 March 2024
- Published by Wiley in JEADV Clinical Practice
- Vol. 3 (4) , 1240-1243
Pityriasis Rubra Pilaris refractory to ustekinumab successfully treated with guselkumab
Pityriasis Rubra Pilaris (PRP) is a rare papulosquamous inflammatory dermatosis with variable clinical presentation and poorly understood pathogenesis that often poses diagnostic and therapeutic challenges. Data on currently available treatment options are limited, particularly when facing refractory cases. Both ustekinumab, an interleukin‐12 (IL‐12) and IL‐23 inhibitor, and guselkumab, an IL‐23p19 inhibitor, target the Th‐17 axis and are well established treatment options in moderate to severe psoriasis. However, increasing evidence, mostly derived from case reports and supported by recent understanding of the role of Th‐17 axis in PRP, also favours the use of IL‐17/IL‐23 pathway inhibitors in this disease. We present an adult female patient with long history of recalcitrant PRP refractory to multiple treatment options. Although initial improvement with ustekinumab was achieved, late disease progression ensued, leading to transition to guselkumab with remarkable clinical response.
- 22 March 2024
- Published by Wiley in JEADV Clinical Practice
- Vol. 3 (4) , 1240-1243
Open AccessPityriasis Rubra Pilaris refractory to ustekinumab successfully treated with guselkumab
Pityriasis Rubra Pilaris (PRP) is a rare papulosquamous inflammatory dermatosis with variable clinical presentation and poorly understood pathogenesis that often poses diagnostic and therapeutic challenges. Data on currently available treatment options are limited, particularly when facing refractory cases. Both ustekinumab, an interleukin‐12 (IL‐12) and IL‐23 inhibitor, and guselkumab, an IL‐23p19 inhibitor, target the Th‐17 axis and are well established treatment options in moderate to severe psoriasis. However, increasing evidence, mostly derived from case reports and supported by recent understanding of the role of Th‐17 axis in PRP, also favours the use of IL‐17/IL‐23 pathway inhibitors in this disease. We present an adult female patient with long history of recalcitrant PRP refractory to multiple treatment options. Although initial improvement with ustekinumab was achieved, late disease progression ensued, leading to transition to guselkumab with remarkable clinical response.
- Open Access
- 13 September 2023
- Published by PAGEPress Publications in Dermatology Reports
- Vol. 16 (3) , 9837
Discoid lupus erythematosus associated with chronic granulomatous disease
To the Editor, Chronic granulomatous disease (CGD) is a primary immunodeficiency disorder in which a reduced activity of nicotinamide dinucleotide phosphate (NAPDH) oxidase leads to defective reactive oxygen intermediates (ROS) and impairs intracellular killing of microorganisms. Patients have recurrent bacterial and fungal infections as well as granuloma formations, and have a higher risk of autoimmune and inflammatory disorders like lupus erythematosus.1 A 20-year-old caucasian male with a diagnosis of autosomal recessive CGD was referred to our hospital because of a pruritic photosensitive rash on the face and hands, present for more than a year.
- 13 September 2023
- Published by PAGEPress Publications in Dermatology Reports
- Vol. 16 (3) , 9837
Open AccessDiscoid lupus erythematosus associated with chronic granulomatous disease
To the Editor, Chronic granulomatous disease (CGD) is a primary immunodeficiency disorder in which a reduced activity of nicotinamide dinucleotide phosphate (NAPDH) oxidase leads to defective reactive oxygen intermediates (ROS) and impairs intracellular killing of microorganisms. Patients have recurrent bacterial and fungal infections as well as granuloma formations, and have a higher risk of autoimmune and inflammatory disorders like lupus erythematosus.1 A 20-year-old caucasian male with a diagnosis of autosomal recessive CGD was referred to our hospital because of a pruritic photosensitive rash on the face and hands, present for more than a year.
- 25 August 2023
- Published by Wiley in International Journal of Dermatology
- Vol. 62 (12) , E617-E618
Dupilumab in the treatment of dystrophic epidermolysis bullosa: off‐label use in a pediatric patient
- 25 August 2023
- Published by Wiley in International Journal of Dermatology
- Vol. 62 (12) , E617-E618
Dupilumab in the treatment of dystrophic epidermolysis bullosa: off‐label use in a pediatric patient
- 11 July 2022
- Published by Wiley in Dermatologic Therapy
- Vol. 35 (9) , e15678
Losartan as therapy for recessive dystrophic epidermolysis bullosa: Report of three cases
- 11 July 2022
- Published by Wiley in Dermatologic Therapy
- Vol. 35 (9) , e15678
Losartan as therapy for recessive dystrophic epidermolysis bullosa: Report of three cases
- 13 June 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 36 (10) , E770-E772
Patch testing in fixed drug eruptions: a 12‐year retrospective study
- 13 June 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 36 (10) , E770-E772
Patch testing in fixed drug eruptions: a 12‐year retrospective study